Location
Located in the heart of the “most innovative square mile on the planet”, Bayer Co.Lab Cambridge is specifically designed to support cutting-edge technologies in oncology, cardiovascular diseases, renal, and immunology, across therapeutic modalities, but with a specific focus on cell and gene therapies (CGT) for CNS and rare diseases. We are co-located within the Bayer Research and Innovation Center (BRIC), Leaps by Bayer, BlueRock Therapeutics, LabCentral, and Beam Therapeutics at 238 Main Street. At Bayer Co.Lab Cambridge, we offer entrepreneurs access to Bayer’s enterprise-wide expertise, along with state-of-the-art laboratories and office space.
All Co.Lab residents have the opportunity to engage, exchange, and share their experiences and ideas across international Bayer Co.Lab locations. Applications are accepted throughout the year.
Our local offering to biotech start-ups
Ready for occupancy
State-of-the-art facilities including benches, shared tissue culture suites, bioanalytical equipment rooms, and cold storage.
Exceptional space
Conveniently on the MBTA Red Line, the facility features workstations, conference rooms for focused meetings, a communal lounge, kitchen, wellness room, and lactation room.
Innovation Hub
A unique incubator network fostering innovation and partnerships, offering access to Bayer's expertise in manufacturing and in industry-leading technologies.
World-class symposiums
Portfolio of programming that showcases technological innovation and provides opportunities for engagement through mentoring, seminars, and professional networking.
Conveniently located
… on MBTA redline.
Partnership with LabCentral
… ensures operational excellence and options of start-up expansion.
Your local contacts
Fiona Mack
VP, Head of Bayer Co.Lab Cambridge
Alberto Nobili
Head of Bayer Co.Lab
Cambridge